Global Duchenne Muscular Dystrophy Drugs Market Size, Share, and COVID-19 Impact Analysis, By Treatment (Molecular Based, Steroid Based, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE May 2025
REPORT ID SI11006
PAGES 245
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Treatment
      2. Market Attractiveness Analysis By Distribution Channel
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising cases, research funding, gene therapy advancements.
    3. Restraints
      1.  High Treatment Costs
    4. Opportunities
      1.  Gene therapy progress, orphan drug incentives, early diagnosis.
    5. Challenges

5.5.1.   High treatment costs, limited options, regulatory hurdles.

  1. Global Duchenne Muscular Dystrophy Drugs Market Analysis and Projection, By Treatment
    1. Segment Overview
    2. Molecular Based
    3. Steroid Based
    4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Others
  2. Global Duchenne Muscular Dystrophy Drugs Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies
  3. Global Duchenne Muscular Dystrophy Drugs Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Duchenne Muscular Dystrophy Drugs Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Duchenne Muscular Dystrophy Drugs Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1. Aurobindo Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Catalyst Pharmaceuticals, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  PTC Therapeutics. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   FibroGen, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   NS Pharma, INC. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Sarepta Therapeutics, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Capricor Therapeutics, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. ITALFARMACO S.p.A.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  EspeRare Foundation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Santhera Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  2. Global Molecular Based, Duchenne Muscular Dystrophy Drugs Market, By Region, 2024-2034(USD Billion)
  3. Global Steroid Based, Duchenne Muscular Dystrophy Drugs Market, By Region, 2024-2034(USD Billion)
  4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Duchenne Muscular Dystrophy Drugs Market, By Region, 2024-2034(USD Billion)
  5. Global Others, Duchenne Muscular Dystrophy Drugs Market, By Region, 2024-2034(USD Billion)
  6. Global Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  7. Global Hospital Pharmacies, Duchenne Muscular Dystrophy Drugs Market, By Region, 2024-2034(USD Billion)
  8. Global Retail Pharmacies, Duchenne Muscular Dystrophy Drugs Market, By Region, 2024-2034(USD Billion)
  9. Global Online Pharmacies, Duchenne Muscular Dystrophy Drugs Market, By Region, 2024-2034(USD Billion)
  10. North America Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  11. North America Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  12. U.S.  Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  13. U.S.  Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  14. Canada Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  15. Canada Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  16. Mexico Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  17. Mexico Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  18. Europe Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  19. Europe Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  20. Germany Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  21. Germany Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  22. France Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  23. France Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  24. U.K.  Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  25. U.K.  Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  26. Italy Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  27. Italy Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  28. Spain Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  29. Spain Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  30. Asia Pacific Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  31. Asia Pacific Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  32. Japan Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  33. Japan Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  34. China Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  35. China Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  36. India Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  37. India Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  38. South America Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  39. South America Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  40. Brazil Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  41. Brazil Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  42. The Middle East and Africa Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD   Billion)
  43. The Middle East and Africa Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD   Billion)
  44. UAE Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  45. UAE Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)
  46. South Africa Duchenne Muscular Dystrophy Drugs Market, By Treatment, 2024-2034(USD Billion)
  47. South Africa Duchenne Muscular Dystrophy Drugs Market, By Distribution Channel, 2024-2034(USD Billion)

List of Figures 

  1. Global Duchenne Muscular Dystrophy Drugs Market Segmentation
  2. Duchenne Muscular Dystrophy Drugs Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Duchenne Muscular Dystrophy Drugs Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Duchenne Muscular Dystrophy Drugs Market
  20. Duchenne Muscular Dystrophy Drugs Market Segmentation, By Treatment
  21. Duchenne Muscular Dystrophy Drugs Market For Molecular Based, By Region, 2024-2034 ($ Billion)
  22.  Duchenne Muscular Dystrophy Drugs Market For Steroid Based, By Region, 2024-2034 ($ Billion)
  23. Duchenne Muscular Dystrophy Drugs Market For Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Region, 2024-2034 ($ Billion)
  24. Duchenne Muscular Dystrophy Drugs Market For Others, By Region, 2024-2034 ($ Billion)
  25.  Duchenne Muscular Dystrophy Drugs Market Segmentation, By Distribution Channel
  26.  Duchenne Muscular Dystrophy Drugs Market For Hospital Pharmacies, By Region, 2024-2034 ($ Billion)
  27.  Duchenne Muscular Dystrophy Drugs Market For Retail Pharmacies, By Region, 2024-2034 ($ Billion)
  28. Duchenne Muscular Dystrophy Drugs Market For Online Pharmacies, By Region, 2024-2034 ($ Billion)

 

  1. Aurobindo Pharma: Net Sales, 2024-2034 ($ Billion)
  2. Aurobindo Pharma: Revenue Share, By Segment, 2024 (%)
  3. Aurobindo Pharma: Revenue Share, By Region, 2024 (%)
  4. Catalyst Pharmaceuticals, Inc.: Net Sales, 2024-2034 ($ Billion)
  5. Catalyst Pharmaceuticals, Inc.: Revenue Share, By Segment, 2024 (%)
  6. Catalyst Pharmaceuticals, Inc.: Revenue Share, By Region, 2024 (%)
  7. PTC Therapeutics.: Net Sales, 2024-2034 ($ Billion)
  8. PTC Therapeutics.: Revenue Share, By Segment, 2024 (%)
  9. PTC Therapeutics.: Revenue Share, By Region, 2024 (%)
  10. FibroGen, Inc.: Net Sales, 2024-2034 ($ Billion)
  11. FibroGen, Inc.: Revenue Share, By Segment, 2024 (%)
  12. FibroGen, Inc.: Revenue Share, By Region, 2024 (%)
  13. NS Pharma, INC.: Net Sales, 2024-2034 ($ Billion)
  14. NS Pharma, INC.: Revenue Share, By Segment, 2024 (%)
  15. NS Pharma, INC.: Revenue Share, By Region, 2024 (%)
  16. Sarepta Therapeutics, Inc.: Net Sales, 2024-2034 ($ Billion)
  17. Sarepta Therapeutics, Inc.: Revenue Share, By Segment, 2024 (%)
  18. Sarepta Therapeutics, Inc.: Revenue Share, By Region, 2024 (%)
  19. Capricor Therapeutics, Inc.: Net Sales, 2024-2034 ($ Billion)
  20. Capricor Therapeutics, Inc.: Revenue Share, By Segment, 2024 (%)
  21. Capricor Therapeutics, Inc.: Revenue Share, By Region, 2024 (%)
  22. ITALFARMACO S.p.A.: Net Sales, 2024-2034 ($ Billion)
  23. ITALFARMACO S.p.A.: Revenue Share, By Segment, 2024 (%)
  24. ITALFARMACO S.p.A.: Revenue Share, By Region, 2024 (%)
  25. EspeRare Foundation.: Net Sales, 2024-2034 ($ Billion)
  26. EspeRare Foundation.: Revenue Share, By Segment, 2024 (%)
  27. EspeRare Foundation.: Revenue Share, By Region, 2024 (%)
  28. Santhera Pharmaceuticals: Net Sales, 2024-2034 ($ Billion)
  29. Santhera Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  30. Santhera Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  31. Others: Net Sales, 2024-2034 ($ Billion)
  32. Others: Revenue Share, By Segment, 2024 (%)
  33. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:122
Pages:245
Countries covered:20
Companies covered::15
Forecast CAGR:14.80%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies